Lisa Francis

<i>N</i> ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial

Zhi‐Wei Lai, Robert Hanczko, Eduardo Bonilla et al. · Arthritis & Rheumatism · 2012 · 400 citations

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Zhi‐Wei Lai, Ryan L. Kelly, Thomas Winans et al. · The Lancet · 2018 · 390 citations

Rheumatology, Autoimmune Disease, Systemic Lupus Erythematosus Treatment +9

Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus Erythematosus

Zhi‐Wei Lai, Rebecca Borsuk, Ashwini Shadakshari et al. · The Journal of Immunology · 2013 · 152 citations · Full text

Brief Report: Attention Deficit and Hyperactivity Disorder Scores Are Elevated and Respond to <i>N</i>‐Acetylcysteine Treatment in Patients With Systemic Lupus Erythematosus

Ricardo Juan Bosch García, Lisa Francis, Maha Dawood et al. · Arthritis & Rheumatism · 2013 · 97 citations · Full text

Infection in systemic lupus erythematosus: friend or foe?

Lisa Francis, András Perl · International Journal of Clinical Rheumatology · 2010 · 63 citations · Full text

Host Response, Rheumatology, Infectious Agents +15